Nalazite se na CroRIS probnoj okolini. Ovdje evidentirani podaci neće biti pohranjeni u Informacijskom sustavu znanosti RH. Ako je ovo greška, CroRIS produkcijskoj okolini moguće je pristupi putem poveznice www.croris.hr
izvor podataka: crosbi

In reply to Swain et al.: Re-evaluation of updated meta-analysis including trials RTOG 1016 and De- ESCALaTE (CROSBI ID 269307)

Prilog u časopisu | Pismo uredniku | međunarodna recenzija

Suton, Petar ; Skelin, Marko ; Rakušić, Zoran ; Dokuzović, Stjepan ; Lukšić, Ivica In reply to Swain et al.: Re-evaluation of updated meta-analysis including trials RTOG 1016 and De- ESCALaTE // European archives of oto-rhino-laryngology, 276 (2019), 7; 2113-2114. doi: 10.1007/s00405-019-05485-7

Podaci o odgovornosti

Suton, Petar ; Skelin, Marko ; Rakušić, Zoran ; Dokuzović, Stjepan ; Lukšić, Ivica

engleski

In reply to Swain et al.: Re-evaluation of updated meta-analysis including trials RTOG 1016 and De- ESCALaTE

We have recently published a meta-analysis in which we have concluded that cisplatin-based chemoradiotherapy should remain standard of definitive treatment for human papilloma virus associated oropharyngeal cancer. In this letter to the editor we have addressed a potential flaws our meta-analysis.

oropharyngeal cancer ; human papilloma virus ; cisplatin ; cetuximab ; survival ; recurrence

nije evidentirano

nije evidentirano

nije evidentirano

nije evidentirano

nije evidentirano

nije evidentirano

Podaci o izdanju

276 (7)

2019.

2113-2114

objavljeno

0937-4477

1434-4726

10.1007/s00405-019-05485-7

Povezanost rada

Kliničke medicinske znanosti

Poveznice
Indeksiranost